Insight

Vedang Murthy: Is 25Gy/5 enough for prophylactic nodal RT in high-risk Prostate Cancer?

Vedang Murthy/X

Jan 4, 2025, 16:23

Vedang Murthy: Is 25Gy/5 enough for prophylactic nodal RT in high-risk Prostate Cancer?

Vedang Murthy, Professor GU-Radiation Oncology at Tata Memorial Centre Mumbai, shared a post on X:

“With the new year, comes new insight.

Is 25Gy/5 enough for prophylactic nodal RT in high-risk Prostate Cancer?

Borrowed from rectal cancer protocols, it has never been validated for prostate SBRT—until now.

The SHARP consortium offers insights.”

Pelvic regional control with 25Gy in 5 fractions in SBRT for high risk prostate cancer: Pooled prospective outcomes from the SHARP consortium

Authors: Vedang Murthy, Indranil Mallick, Priyamvada Maitre, Gargee Mulye, Moses Arunsingh, Luca Valle, Michael Steinberg, Thomas Kennedy, Andrew Loblaw, Amar U Kishan.

Vedang Murthy

Amar U. Kishan Andrew Loblaw cancer Gargee Mulye Indranil Mallick Luca Valle Michael Steinberg Moses Arunsingh OncoDaily Oncology Priyamvada Maitre prostate cancer rectal cancer Thomas Kennedy Vedang Murthy

Senator John Fetterman Responds to Oncodaily on Pediatric Oncology Funding

Does Processed Meat Cause Cancer? Myths and Facts

Global Health Dialogues with Princess Dina Mired | Episode 1: Dr. Firas Al-Hawari

NEW PAPER ALERT: ESOPEC trial on Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer

Oncologist Near Me - Matti Aapro: Pioneering Excellence in Cancer Care and Geriatric Oncology